OCT 24, 2019 12:00 PM PDT

The Science of Hemp

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • CTO, ZED Therapeuti
    Biography
      Zacariah L. Hildenbrand received his bachelors of science and Ph.D. degrees from the University of Texas at El Paso, where he also played on the men's intercollegiate golf team. Dr. Hildenbrand continued his training as a post-doctoral research fellow at the University of Texas Southwestern Medical Center in Dallas where he worked on novel therapies for the treatment of blood-borne cancers.

      Dr. Hildenbrand is the Chief Technical Officer of ZED Therapeutics, and sits on the scientific advisory board of the Collaborative Laboratories for Environmental Analysis and Remediation at the University of Texas at Arlington, and is a director of the Light Engines Design Corporation (OTC:TLED). Dr. Hildenbrand also sits on the Editorial Advisory Board of Cannabis Science and Technology. Dr. Hildenbrand's research has produced more than 60 peer-reviewed scientific journal articles and textbook chapters, and was nominated for the 2016 Humanity in Science Award, which recognizes scientists for their altruism and innovation. Dr. Hildenbrand is focused on educating the general public about the scientific merits of hemp, as well as developing new innovations with hemp-based therapies. Dr. Hildenbrand enjoys new research challenges that carry deep social significance and he is driven to provide solutions and find more efficient treatments for those struggling with illness.

    Abstract

    The emergence of medicinal hemp represents a new frontier in medicine; one which has tremendous potential for patients struggling with a wide array of illnesses. However, in order to fully capitalize on the therapeutic benefits that are provided by the native hemp constituents, its chemical composition must be first characterized. This presentation will cover the various classes of constituents found in hemp, as well as the analytical tools that are required for their characterization.


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    APR 27, 2020 9:00 AM PDT
    C.E. CREDITS
    APR 27, 2020 9:00 AM PDT
    DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
    MAY 04, 2020 9:00 AM PDT
    C.E. CREDITS
    MAY 04, 2020 9:00 AM PDT
    DATE: May 4, 2020 TIME: 9:00am PT, 12:00pm ET...
    Loading Comments...
    Show Resources
    Attendees
    • See more